Document is current

Article History

Received: 2 September 2024

Revised: 13 December 2024

Accepted: 30 December 2024

First Online: 22 January 2025

Declarations

:

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (SOMNIA: Maxima Medical Center, Eindhoven, the Netherlands, File no: N16.074, SHHS/MESA: refer to original publications) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.

: Informed consent was obtained from all individual participants included in the study. For this particular retrospective study, formal consent was not required.

: All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers' bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript. L.C., G.P., and P.F. were employed and/or affiliated with Royal Philips. R.V. is co-founder and shareholder of Nemo Healthcare BV. S.O. received an unrestricted research grant from UCB Pharma and participated in advisory boards for Jazz Pharmaceuticals, Bioprojet, and Abbvie. None of these companies had a role in the study design, decision to publish, or preparation of the manuscript.